warfarin and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

warfarin has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 2 studies

Other Studies

2 other study(ies) available for warfarin and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

ArticleYear
Network meta-analysis: a new analysis tool of the experimental evidence.
    Minerva medica, 2019, Volume: 110, Issue:2

    Topics: Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Dabigatran; Dasatinib; Data Interpretation, Statistical; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Network Meta-Analysis; Pyrimidines; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Warfarin

2019
Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy.
    Leukemia research, 2010, Volume: 34, Issue:8

    Topics: Aged; Anticoagulants; Antineoplastic Agents; Benzamides; Drug Therapy, Combination; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Treatment Outcome; Warfarin

2010